XML 53 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity Financing - Additional Information (Detail) - USD ($)
1 Months Ended 9 Months Ended
Aug. 17, 2018
Aug. 14, 2018
Feb. 28, 2018
Oct. 31, 2017
Jan. 31, 2017
Sep. 30, 2018
Sep. 30, 2017
Apr. 30, 2017
2017 Placement Warrants                
Equity Financing [Line Items]                
Warrants to purchase common stock, shares         1,720,512      
Warrant exercise price         $ 3.17 $ 3.17    
Warrant expiration date         Jan. 31, 2024      
Warrant exercisable date         Jul. 31, 2017      
Underwriters | Common Stock                
Equity Financing [Line Items]                
Underwriting agreement date   Aug. 14, 2018            
Number of shares issued in transaction   16,216,217            
Sale of stock, price   $ 9.25            
Option to purchase additional shares   30 days            
Aggregate proceeds from issuance of common stock $ 161,900,000              
Underwriters | Common Stock | Maximum                
Equity Financing [Line Items]                
Number of additional shares issued in transaction   2,432,432            
2017 Direct Registered Offering                
Equity Financing [Line Items]                
Aggregate proceeds from issuance of common stock       $ 49,900,000        
2017 Direct Registered Offering | Common Stock                
Equity Financing [Line Items]                
Stock issued during period       8,382,643        
March 2018 Direct Registered Offering                
Equity Financing [Line Items]                
Warrants to purchase common stock, shares     1,418,116          
Proceed from private placement and equity issuances, gross     $ 59,100,000          
Warrant exercise price     $ 8.31          
Warrant expiration date     Mar. 31, 2025          
March 2018 Direct Registered Offering | Common Stock                
Equity Financing [Line Items]                
Stock issued during period     4,090,000          
March 2018 Direct Registered Offering | Series A Convertible Preferred Stock                
Equity Financing [Line Items]                
Stock issued during period     3,000,581          
2017 Private Placement | Common Stock                
Equity Financing [Line Items]                
Number of shares issued in transaction         8,602,589      
Proceed from private placement and equity issuances, gross         $ 26,100,000      
At The Market Offering Program                
Equity Financing [Line Items]                
Aggregate proceeds from issuance of common stock           $ 278,000 $ 40,126,000  
Average market price per share           $ 8.41    
At The Market Offering Program | Maximum                
Equity Financing [Line Items]                
Maximum aggregate offering price         $ 75,000,000      
Maximum common stock saleable shares, value               $ 50,000,000
At The Market Offering Program | Common Stock                
Equity Financing [Line Items]                
Stock issued during period           33,097